|Articles|January 2, 2004

Pharmaceutical Technology

  • Pharmaceutical Technology-01-02-2004
  • Volume 28
  • Issue 1

The Bioterrorism Act

Two FDA final rules issued in response to the Bioterrorism Response Act of 2002 may significantly affect the supply and importation of pharmaceutical excipients.

Articles in this issue

Related to this article

CPHI Milan 2026: Trends in Pharma
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.